Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Finance Home
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
The New Investors
All Markets Summit
Give Feedback
Australia markets closed
ALL ORDS
7,312.40
+76.40
(+1.06%)
AUD/USD
0.6708
+0.0021
(+0.32%)
ASX 200
7,122.30
+72.00
(+1.02%)
OIL
73.15
+0.18
(+0.25%)
GOLD
1,965.30
-1.60
(-0.08%)
Bitcoin AUD
42,697.35
+1,654.48
(+4.03%)
✉️ Sign up
Get our best money-saving hacks and pro tips now
Heron Therapeutics, Inc. (HRTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6900
+0.0800
(+4.97%)
At close: 04:00PM EDT
1.7100
+0.02
(+1.18%)
After hours:
07:34PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
-
86,346
88,638
145,968
Cost of revenue
-
46,021
36,189
61,619
Gross profit
-
40,325
52,449
84,349
Operating expenses
Research development
-
130,821
174,533
167,382
Selling general and administrative
-
127,332
106,079
127,661
Total operating expenses
-
258,153
280,612
295,043
Operating income or loss
-
-217,828
-228,163
-210,694
Interest expense
-
2,410
1,901
1,472
Total other income/expenses net
-
-878
-847
158
Income before tax
-
-220,683
-227,278
-204,749
Income from continuing operations
-
-220,683
-227,278
-204,749
Net income
-
-220,683
-227,278
-204,749
Net income available to common shareholders
-
-220,683
-227,278
-204,749
Basic EPS
-
-2.24
-2.50
-2.50
Diluted EPS
-
-2.24
-2.50
-2.50
Basic average shares
-
98,471
90,774
81,779
Diluted average shares
-
98,471
90,774
81,779
EBITDA
-
-215,252
-222,530
-201,233
© 2023 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Terms
Privacy
Privacy Dashboard
About our ads